Maternal smoking during pregnancy contributes to long-term health problems in offspring, 33 especially respiratory disorders which can manifest in either childhood or adulthood. Receptors for 34 advanced glycation end-products (RAGE) are multi-ligand receptors abundantly localized in the 35 lung, capable of responding to by-products of reactive oxygen species and pro-inflammatory 36 responses. RAGE signalling is a key regulator of inflammation in cigarette smoking-related 37 pulmonary diseases. However, the impact of maternal cigarette smoke exposure on lung RAGE 38 signalling in the offspring is unclear. This study aims to investigate the effect of maternal cigarette 39 smoke exposure (SE), as well as MitoQ (mitochondria-targeted antioxidant) treatment during 40 pregnancy on RAGE-mediated signalling pathway in the lung of male offspring. 41
while IL-1β and oxidative stress response nuclear factor (erythroid-derived 2)-like 2 (Nrf-2) was 48 significantly increased in the SE offspring. Maternal MitoQ treatment normalised RAGE, Nrf-2 levels in the SE+MQ offspring. 50
Maternal SE increased RAGE and its signalling elements associated with increased oxidative stress 51 and inflammatory cytokines in offspring's lungs; whereas maternal MitoQ treatment can partially 52 normalise these changes. 53
INTRODUCTION 55
Maternal smoking during pregnancy contributes to various long-term health problems in offspring, 56 especially respiratory disorders (21, 37) . Several human studies have indicated that maternal 57 smoking is associated with lung under-development, airflow limitations, increase in the risk of 58 respiratory infections and development of airway hypersensitivity and asthma (7, 62, 64) . Several 59 mechanisms have been proposed, including a reduction in the development or physical size of the 60 lung including reduced elastic tissue and the number of alveolar attachments to the airway, an 61 increase in oxidative stress, and alteration to the inflammatory response and immune system (14, 62 17, 41, 42) . 63 64 Receptors for advanced glycation end-products (RAGE) are multi-ligand receptors abundantly 65 localized in the lung (16) . Recent studies have implied a role of RAGE in cigarette-smoking-related 66 diseases, where RAGE signaling is a key regulator of inflammatory response in pulmonary diseases 67 (13, 48) . Cigarette smoke induces the formation of advanced glycation end-products (AGEs), 68 resulting in the development of diseases through the AGEs-RAGE axis (8, 44) . Indeed, it has been 69 reported that serum levels of AGEs are elevated in smokers including both current and past smokers 70 (40), and RAGE levels are elevated in pulmonary tissue from mice exposed to cigarette smoke (20, 71 65) . AGEs can interact with RAGE leading to pro-inflammatory responses via several downstream 72 kinases, such as the Mitogen-activated protein kinase (MAPK) family consisting of extracellular 73 signal-regulated kinase-1/2 (ERK1/2), c-JUN N-terminal kinase (JNK) and p38MAPK. The 74 transcription factor nuclear factor-κ -light-chain-enhancer of activated B cells (NF-κB) can also be 75 activated, which results in the expression of a variety of pro-inflammatory mediators and cytokines, 76
including IL-1, 32, 45) . Thus, the activation of RAGE-mediated signalling 77 pathways is likely to play a key role to mediate inflammatory response in many pulmonary 78 disorders (47). In a previous study, short-term maternal cigarette smoke exposure during embryo 79 days 14.5-18.5 was shown to increased RAGE level in the fetal lung tissue at embryo day 18.5 80 (63). However, whether such changes are still present at adulthood is unknown. 81 82 Pathological responses induced by the AGEs-RAGE axis are mediated by the generation of 83 intracellular reactive oxygen species (ROS), the ensuing oxidative stress (15), and the activation of 84 ROS induced cytokine production and inflammation. Mitochondria are the major cellular source of 85 ROS (59), and as such are a pharmacological target for ROS production. It is well established that 86 oxidative stress can induce the secretion of inflammatory cytokines and the expression of adhesion 87 molecules and inflammatory mediators in the lung (3, 24, 27) . It has also been shown that maternal 88 smoking can significantly increase oxidative stress in the offspring, including the lung tissue (4). 89
Therefore, reducing oxidative stress may reduce pulmonary inflammatory responses in the lungs of 90 offspring from smoking parents. 91 92 Coenzyme Q10 (CoQ10) is a mitochondrial endogenous antioxidant. It has been shown that CoQ10 93 dietary supplementation (1%) in mice with diet-induced obesity can lower liver markers of 94 inflammation and oxidative stress (55). Plasma CoQ10 levels are reduced in smokers (1). However, 95 mitochondrial intake of commercial CoQ10 is very low via oral supplementation, thus a 96 superphysiological dose was used in the abovementioned study. Mitoquinone mesylate, also known 97 as MitoQ, is a mitochondria-targeted antioxidant. It consists of a ubiquinone moiety, the same 98 structure to the ubiquinone found in CoQ10 that is linked to a triphenylphosphonium moiety by a 99 ten-carbon alkyl chain, which allows its rapid uptake and accumulation in the mitochondria to 100 restore the antioxidant efficacy of the mitochondrial respiratory complex (26). As such, it has been 101 reported that MitoQ has a protective role against oxidative damage-related pathologies in metabolic 102 disease (36) and neurodegenerative diseases (34). Amniotic fluid CoQ10 levels are significantly 103 lower among women delivering preterm babies, a risk which is increased by maternal smoking (29, 104 60) . Therefore, MitoQ might be a suitable intervention option since it is already marked for human 105 consumption. 106 107 Thus, the main aim of this study was to investigate the long-term impact of maternal cigarette 108 smoke exposure (SE) on lung RAGE signalling elements in adult offspring. In addition, whether 109
MitoQ supplementation during gestation can mitigate the adverse impact of maternal SE was also 110 investigated. 111
112

MATERIALS AND METHODS 113
Animal experiments 114
The animal experiments were approved by the Animal Care and Ethics Committee at the University water. After the acclimatisation period, mice were divided into the following three groups: sham 120 (exposed to air), SE (exposed to 2 cigarettes twice daily, 6 weeks before mating and throughout 121 gestation and lactation, as previously described (2)), and SEMQ (SE mothers supplied with MitoQ 122
(1.5 g/L in drinking water) during gestation and lactation). This dose was chosen as it has 123 previously shown to be effective, safe and maintain steady-state tissue concentrations of 1-100 pmol 124
MitoQ/per g of tissue(36, 49) (depending upon the organ analysed; MitoQ accumulates in liver and 125 heart, but is effective in the lung with this dosing regimen (33)). Male breeders and suckling pups 126 stayed in the home cage when mothers were exposed to sham or cigarette smoke. Pups were 127 weaned at postnatal day 20 and maintained without additional intervention. Male offspring were 128 euthanized (4% isoflurane, 1% O 2 , Veterinary companies of Australia, Kings Park, NSW) at 13 129 weeks (mature age) and the lung tissues were collected and stored at -80°C for later analysis. 130 131
Western blotting 132
Lungs tissues were homogenized in lysis buffer with phosphatase inhibitors (Thermo Fisher  133 Scientific, CA, USA). Protein concentrations were measured using DC Protein assay 134 Hercules, CA, USA). Equal amount of proteins (20 μg) were separated on NuPage® Novex® 4-135 12% Bis-Tris gels (Thermo Fisher Scientific, CA, USA) and transferred to PVDF membranes. The 136 membranes were blocked with TBS-0.05% Tween 20 (TBS-T) containing 5% BSA or skim milk 137 for 1 h, before incubation with primary antibodies against phospho-Erk1/2 (1:1000, Cell Signaling 138 Technology Inc), Erk1/2 (1:1000, Cell Signaling Technology Inc, MA, USA), phospho-JNK 139
(1:1000, Cell Signaling Technology Inc, MA, USA), JNK (1:500, Cell Signaling Technology Inc, 140 MA, USA), phospho-p38 MAPK (1:1000, Cell Signaling Technology Inc, MA, USA), p38 MAPK 141
(1:1000, Cell Signaling Technology Inc, MA, USA), NF-κB and phospho-NF-κB (1:1000, Cell 142
Signaling Technology Inc, MA, USA), IL-6 (1:1000, Cell Signaling Technology Inc, MA, USA), 143 IL-1β (1:1000, Cell Signaling Technology Inc, MA, USA), RAGE (1:1000, GeneTex Inc, CA, 144 USA), TNF-α (1:1000, Gene Tex Inc, CA, USA), antioxidant response element nuclear factor 145 (erythroid-derived 2)-like 2 (Nrf-2, 1:500, Aviva System Biology, CA, USA), endogenous 146 antioxidant Manganese superoxide dismutase (MnSOD, 1:1000, Santa Cruz Biotechnology, Texas, 147 USA), transforming growth factor-β1 (TGF-β1, 1:500, R&D Systems, MN, USA), and collagen 1A 148
(1:1000, Santa Cruz Biotechnology Inc, Texas, USA) overnight at 4°C, which was followed by 149 secondary antibodies (peroxidase-conjugated goat anti-mouse or anti-rabbit IgG, 1:2000, Santa 150
Cruz Biotechnology Inc). The blots were then incubated in Super Signal West Pico 
Effect on lung RAGE and MAPK signalling elements in offspring 187
Maternal smoking increased the amount of RAGE protein in adult offspring's lungs (P<0.05 vs 188 SHAM; Fig. 1a ) which was reduced by MitoQ. At the mRNA level, RAGE was only slightly 189 reduced in the SE offspring at 13 weeks, but increased by MitoQ (Fig.1b) . RAGE downstream 190 signalling molecules including total Erk1, Erk2, JNK, and p-JNK protein levels were increased in 191 SE offspring (P<0.05 vs SHAM; Fig.2 a-c) ; however, p-Erk1 and p-Erk2 levels were not different 192 between SHAM and SE group. There was no change in total or phosphorylated p38MAPK between 193 the SHAM and SE groups (Fig. 2d ). Maternal MitoQ supplementation during gestation marginally 194 reduced total ERK1 and ERK2, as well as p-ERK1 and p-ERK2 levels, although without statistical 195 significance (Fig 2) . 196
197
Effects on lung antioxidant enzyme in offspring 198
Manganese superoxide dismutase (MnSOD) is the primary endogenous mitochondrial antioxidant 199 that plays a key role in protecting cells against oxidative stress. As shown in Figure 3 , 200 mitochondrial levels of MnSOD were significantly reduced in the SE offspring (P < 0.05), which 201 was only slightly enhanced by maternal MitoQ treatment. Furthermore, Nrf-2, a transcription factor 202 which is high sensitivity to oxidative stress, was significantly increased in the SE offspring (P < 203 0.05 vs SHAM; Fig. 4a ), which was normalised by maternal MitoQ supplemenation (P<0.05 vs 204 SE; Fig. 4b ). 205 206
Effects on lung pro-inflammatory mediators in offspring 207
RAGE-induced release of pro-inflammatory cytokines is mainly via the activation of NF-κB, a 208 redox-sensitive transcription factor that regulates the transcription of several pro-inflammatory 209 cytokines. There was a nonsignificant trend towards increasing levels of phosphorylated NF-κB in 210 SE offspring, and the the total NF-κB level was significantly increased in SE offspring compared to 211 SHAM offspring (P < 0.05; Fig.4a,b) . As a result, the ratio of phosphorylated NF-κB / total NF-κB 212 was unchanged. Similarly, IL-1β protein level was more than doubled in SE offspring (P < 0.05; 213 Fig. 4b ), while TNF-α level was increased by 50%, albeit without statistical significance (Fig. 4d) , 214
However, IL-6 levels were similar between the SHAM and SE group (Fig. 4c) . Maternal MitoQ 215 supplementation normalised phosphorylated and total NF-κB and IL-1β levels in SEMQ offspring 216 (Fig 4a,b) , without any effect on IL-6 and TNF-α (Fig 4c,d) . 217 218
Effect on lung fibrotic markers in offspring 219
A prolonged increase in TGF-β1 activity can lead to persistent lung fibrosis resulting in excessive 220 production of collagen-1A (11). Here, neither TGF-β1 nor collagen-1A proteins levels were 221 changed in 13 weeks old SE offspring (Fig.5) . Maternal MitoQ treatment also showed no impact on 222 these two proteins (Fig.5) . 223
224
DISCUSSION 225
Maternal smoking during pregnancy has been shown to adversely affect fetal lung development and 226 has also been linked to an increased risk of long-term respiratory disorders (21, 37) . In this study, 227
we found that SE offspring had reduced body weight at birth which was maintained until adulthood. 228
The protein levels of RAGE and its downstream signalling, including NF-κB and MAPK family 229 consisting of ERK1, ERK2, JNK, and p-JNK, were significantly increased in the lung of SE 230 offspring, with increased inflammatory cytokine IL-1β level. Mitochondrial antioxidant MnSOD 231 levels were reduced, and the oxidative stress response Nrf-2 was significantly increased in the SE 232 offspring. Maternal MitoQ treatment reversed the impact of maternal SE on birth weight and 233 normalised RAGE, NF-κB, IL-1β and Nrf-2 levels in offspring. 234 235 RAGE plays an important role in cigarette-smoking-related diseases as a key regulator in 236 maintaining and promoting inflammatory responses (13, 48, 57) . It has been shown that the 237 expression of RAGE is increased in pulmonary epithelial cells after exposure to cigarette smoke 238 extract (46), whereas increased inflammatory cytokines have been found in the lung lavage fluid of 239 smokers and mice exposed to cigarette smoke (25, 28). To our knowledge, this is the first study to 240 demonstrate that continuous maternal SE from pre-gestation to lactation leads to increased RAGE 241 expression in the offspring's lung at adulthood, with increased downstream signalling elements and 242 inflammatory cytokines. The study by Winden et al. only showed RAGE augmentation in the fetal 243 lung following 4 days maternal SE during the pseudoglandular period of lung development (63). 244 This suggests that the changes in RAGE and signaling elements by maternal SE can begin in the 245 intrauterine period, and last long into adulthood. In our study, RAGE mRNA expression was 246 marginally suppressed (non-significantly) in the SE offspring, which may be due to a negative 247 feedback loop. This suggests that the level of RAGE may be regulated at a transcriptional level. 248
Additional studies will be required to determine the exact mechanism, such as the involvement of 249 transcriptional regulator non-coding RNAs. 250
251
The activation of RAGE signaling pathways can influence alveolar remodeling characteristics of 252 pulmonary disease (50). Several studies have indicated that cigarette smoke induces the expression 253 of RAGE and promotes the phosphorylation of ERK1/2, p38 and JNK in primary human gingival 254 epithelial cells and in the lungs of rats exposed to cigarette smoke (52, 65, 66) . Therefore, here we 255 investigated the signal transduction pathways and fibrotic markers in lung tissue. In the present 256 study, we demonstrated that maternal SE can increase the expression of RAGE-dependent 257 signalling protein kinases including Erk1, Erk2, and JNK. However, the phosphorylation of these 258 molecules was not significantly increased by maternal SE. Therefore, the impact of maternal SE on 259 the health outcome of the offspring's lung may prime the lung to be hyperresponsive to certain 260 stimuli, but the pathways themselves are not intrinsically activated. This is consistent with studies 261 in humans, where smoking during pregnancy is a risk factor for the development of lung diseases 262 such as asthma and COPD, but in both of these diseases other environmental stimuli are mostly 263 needed to develop the disease in children. 264
265
The two fibrotic markers measured in this study were not affected by maternal SE. This is 266 consistent with the changes in fibrotic markers in the kidney in our previous study using the same 267 model of maternal SE (2). Increased collagen deposition has been found in foetal lung tissue of 268 monkeys due to maternal nicotine administration (51). Such differences may be due to the dose of 269 nicotine administered. In our study the nicotine dose was low (equivalent to a human smoking 1-2 270 cigarettes/day). The other significant difference is that cigarette smoke is a complex mixture of 271 chemicals which may inhibit or enhance the effects of nicotine. 272 273 Cigarette smoke contains free radicals, and itself can stimulate the production of ROS in lung 274 tissues, leading to oxidative damage in both pregnant women and newborns (12, 18) . MnSOD is an 275 enzyme present in mitochondria that is one of the first-line enzymes to detoxify the superoxide 276 radicals generated during ATP synthesis (6). Here we showed that the level of mitochondrial 277
MnSOD was reduced in the offspring's lung in response to maternal SE. This is consistent with our 278 findings in the brain and kidneys of SE offspring in adulthood in our previous studies (10, 56) . 279 RAGE activation by multiple ligands such as ceramides, cigarette smoke (39), or intracellular 280 amyloid-β peptide (58) results in mitochondrial damage, likely mediated via mitochondrial ROS production (22). Given this it is likely that reduced MnSOD in the current experiments is the result 282 of mitochondrial damage. 283 284 Additionally, Nrf2 is a transcription factor that responds to oxidative stress and contributes to the 285 induction of several protective enzymes to scavenge excess free radicals during oxidative stress. 286
Nrf2 was found be increased in moderate smokers in response to increased oxidative stress induced 287 by cigarette smoke (19) . Here, we found that Nrf2 was significantly increased in the SE offspring at 288 adulthood, in line with their increased oxidative stress markers. Taken together, maternal cigarette 289 smoking during pregnancy may cause long lasting oxidative stress in offspring's lungs, possibly due 290 to the reduction of protective antioxidative enzymes. 291 292 Prolonged oxidative stress can activate the redox-sensitive transcription factor NF-B (61), which, 293 in turn, results in the transcription of a variety of mRNA encoding pro-inflammatory cytokines (43) . 294
In the present study, the level of NF-κB in offspring from SE mothers was higher than those from 295 the SHAM mothers. This is in keeping with increased protein levels of the pro-inflammatory 296 cytokines interleukin-1β and TNF-α, both of which are the downstream targets of NF-κB. It has 297 been reported that chronic production of IL-1β can lead to pulmonary inflammation, emphysema, 298 airway remodelling, and bronchial hyper-reactivity which are the main features of asthma and 299 COPD (23, 31, 35) . Therefore, maternal smoking during pregnancy may increase the risk of chronic 300 inflammatory conditions in offspring's lungs, making them more susceptible to certain pulmonary 301 disorders such as COPD in adulthood, which requires further investigation. 302
303
Mitochondrial oxidative damage occurs in many disease states. Therefore, strategies to prevent 304 oxidative-stress-induced damage may provide new therapeutic options for a range of human 305 disorders, including lung diseases (5). MitoQ is, to date, the best-characterised mitochondria-306 targeted ubiquinone (53), which reduces the potent antioxidant mitoquinol in the mitochondria (26). 307
MitoQ has been used in several organ systems, but as far as we know never before for pulmonary 308 disorders (9, 36, 38, 54) . In the present study, we determined the effects of maternal MitoQ 309 supplementation during pregnancy on the health outcome of the lungs in offspring. Although 310 maternal MitoQ treatment in SE mothers did not affect endogenous MnSOD level in the offspring, 311 oxidative stress seems to be reduced, reflected by normalised Nrf-2 level. RAGE levels in the 312 SEMQ offspring were also reduced. The activity of MAP kinase family members did not seem to be 313 involved in the action of MitoQ. However, NF-κB was normalised by maternal intervention, which 314 can further normalise pro-inflammatory cytokine levels analysed by one-way ANOVA. SE: smoke exposed; SEMQ: smoke exposed with dietary 553 supplementation of MitoQ; TGF-β1: Transforming growth factor β1. 554 555 556 557
